K-BioGateway secures 1.2 billion won in seed funding led by Korea Technology Finance Corporation. The green bio material startup will use proceeds for DH24 probiotic R&D and global expansion.
Amount Raised
₩1.2 Billion
Round Type
Seed
South KoreaBiotechnologyHealth CareNutritionInvestors
Description
K-BioGateway, a green bio functional material startup founded last year, has secured approximately 1.2 billion won in seed funding. The round was led by Korea Technology Finance Corporation, with participation from Bluepoint Partners and Y&Archer. The company develops functional ingredients for healthy aging, with DH24 as its flagship functional probiotic strain targeting body fat reduction and anti-inflammatory benefits. Proceeds will fund DH24-based product R&D, production capacity expansion, and global clinical trials and regulatory approvals.
Quick answer
K-BioGateway raised ₩1.2 Billion in a Seed round, dated September 21, 2026. Investors: Bluepoint Partners, Korea Technology Finance Corporation and Y&Archer. K-BioGateway is based in South Korea.
- How much did K-BioGateway raise?
- K-BioGateway raised ₩1.2 Billion in a Seed round on September 21, 2026.
- Who invested in K-BioGateway?
- Bluepoint Partners, Korea Technology Finance Corporation and Y&Archer are named as investors in this round.
- What does K-BioGateway do?
- K-BioGateway is a green bio functional material startup founded last year that specializes in research and development of functional ingredients supporting healthy and beautiful aging.
- Where is K-BioGateway based and how big is it?
- K-BioGateway is based in South Korea.
Source: Fundz verified event record.
Who else raised in Nutrition and Biotechnology around the same time
Companies in the same sectors as K-BioGateway that raised within 45 days of this round, from Fundz verified event records.
- The Stack raised $2.3M (Seed) on October 14, 2026.
- Mangoceuticals raised $1.3M (Post-IPO Equity) on October 1, 2026.
- ArrayPatch raised $3.6M (Seed) on November 5, 2026.
- Alethio raised $90M (Series A) on November 5, 2026.
- Biograil raised $22M on November 4, 2026.
- Emvena Therapeutics raised an undisclosed amount (Seed) on November 4, 2026.
Who to call at K-BioGateway, and when
A new round usually means K-BioGateway is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day K-BioGateway raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at K-BioGateway, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at K-BioGateway. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment K-BioGateway raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
K-BioGateway raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.